Biomea Fusion Current Deferred Revenue (Quarterly) Trends

Biomea Fusion, Inc. (BMEA)

1.22 +0.01 (+0.83%) USD | NASDAQ | Dec 30, 16:00

1.22 0.00 (0.00%) Pre-Market: 08:38

View Current Deferred Revenue (Quarterly) for BMEA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Humacyte, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--
Oragenics, Inc.	--